It will seek label expansions thereafter, including in targeting painful lumbosacral radiculopathy (LSR, a condition that ...

It will seek label expansions thereafter, including in targeting painful lumbosacral radiculopathy (LSR, a condition that results from a pinched or inflamed nerve in the lower back). Vertex ...

Vertex Pharmaceuticals Incorporated VRTX announced results from its Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR), a disorder that causes pain in the lower back and hip ...

announced results from its Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR), a disorder that causes pain in the lower back and hip that radiates down the back of the thigh ...

Lumbosacral radiculopathy is a neurologic condition that occurs when a nerve root in the lower back is compressed or irritated. Millions of patients suffer from pain due to LSR every year.

Vertex Pharmaceuticals Inc.’s non-addictive drug helped patients with lower back pain, moving the company closer to selling an alternative to opioids in another type of pain.The mid-stage trial hit ...

In fact, as with other HNPs, the patient can be totally asymptomatic with a central HNP, have back pain only, and have unilateral or bilateral radiculopathy without weakness or sphincter dysfunction.

Vertex Pharmaceuticals shares fell after the company reported mixed results from a study of a treatment for patients with lumbosacral radiculopathy, a neurological disorder that causes back and ...

Hoping to show the drug’s versatility, Vertex also sponsored a mid-stage trial focused on painful “lumbosacral radiculopathy,” or LSR, a common condition in which nerves in the lower back become ...